首頁 > 市場調查報告書 > 製藥

臨床實驗

市場調查報告書

商品編碼

1347168

2028 年內皮功能障礙市場預測 - 按原因、測試類型和最終用戶進行的全球分析

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User

出版日期: 2023年08月09日 | 出版商:

The Insight Partners | 英文 198 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年全球內皮功能障礙市場規模為19.9517億美元，預計到2028年將達到25.8484億美元；預計2022年至2028年該市場的年複合成長率為4.4%。市場成長歸因於心血管疾病發病率的上升以及高膽固醇、糖尿病和肥胖症發病率的上升。

根據世界衛生組織 (WHO) 的數據，心血管疾病 (CVD) 是全球主要死亡原因之一，每年約有 3000 萬人中風。 CVD包括腦血管疾病、冠心病、風濕性心臟病和冠狀動脈疾病(CAD)。 CAD是所有心血管疾病中最常見的疾病，其特徵是脂質和免疫細胞在冠狀動脈內皮下間隙積聚或動脈粥樣硬化。它涉及血管內皮的炎症反應。 CAD的特徵是由於動脈粥樣硬化導致冠狀動脈管腔變窄、痙攣或阻塞而導致心肌缺血、缺氧或壞死。它已成為全世界死亡的主要原因。根據美國疾病控制與預防中心 (CDC) 的數據，美國有超過 6000 萬女性 (44%) 患有某種形式的心臟病。心臟病是美國女性死亡的主要原因，可以影響任何年齡段的女性。 2021年，它造成了310,661名女性死亡，即近五分之一的女性死亡。新德里國家心臟研究所首席執行官兼首席心臟外科醫生O. Yadava 博士在一篇題為“年輕印度人患冠狀動脈疾病的風險較高”的文章中指出，當前的科學證據顯示了令人震驚的結果；印度人的 CAD 發病率比任何其他族裔高出驚人的 50-400%。過去三十年來，西方 CAD 的患病率下降了一半。然而，印度的利率已經翻倍，並且沒有下降的跡象。

根據美國心臟協會的數據，美國幾乎一半的成年人患有某種類型的心血管疾病。預計到2035 年，將有超過1.3 億人（即美國人口的45.1%）患有某種類型的心血管疾病。根據歐洲心臟病學會的報告，心血管疾病在歐洲導致390 萬人死亡，在歐洲造成超過180 萬人死亡。歐盟（EU）。簡而言之，他們佔歐洲所有死亡人數的 45%。過去25年來，歐洲CVD病例和新發CVD病例的絕對數量有所增加。由於男性吸煙習慣和酗酒率，中歐和西歐心血管危險因素的患病率很高。每年有超過 400 萬歐洲人死於心血管疾病，主要是冠狀動脈疾病 (CHD) 和中風。根據 Biosense Webster 2019 年發布的報告《超越負擔：心房顫動對亞太地區的影響》，亞太地區有超過 1600 萬人患有心房顫動，預計到 2050 年這一數位將達到約 7200 萬人報告還表明，中老年人群更容易出現這種情況。

根據世界心臟聯合會的數據，心血管疾病是中東和北非地區的首要死因，佔所有死亡人數的三分之一以上，即每年 140 萬人。此外，過去30年CVD死亡人數增加了48%，分別佔阿曼和索馬里死亡人數的40%和10%。 2021年，中東和北非地區年齡標準化CVD死亡率為每10萬人134.2至600.2。

因此，心血管疾病的高患病率可能會推動內皮功能障礙市場的成長。

基於產品的見解

內皮功能障礙市場根據原因分為高血壓、糖尿病、高膽固醇血症、白塞病、肥胖等。高血壓細分市場在 2022 年佔據最大市場佔有率。然而，預計糖尿病細分市場在 2022 年至 2028 年期間的年複合成長率最高，為 4.6%。心血管併發症是糖尿病引起的慢性血管併發症的結果。許多研究文章表明胰島素抵抗與內皮功能障礙之間存在聯繫。然而，目前尚不清楚糖尿病如何影響內皮細胞。糖尿病與微血管病變的風險直接相關，例如動脈粥樣硬化性疾病、視網膜病變、腎病和神經病變。因此，患有糖尿病的患者患心血管疾病的風險呈指數增加。根據MDPI 期刊2020 年5 月發表的研究文章“糖尿病中的內皮功能障礙”，患有糖尿病前期疾病（例如空腹血糖受損(IFG) 和糖耐量受損(IGT)）的患者也顯示出越來越多的證據表明內皮功能障礙與一個事件。考慮到上述因素，內皮功能障礙治療的需求預計將呈指數級成長。

基於原因的見解

根據病因，內皮功能障礙市場分為高血壓、糖尿病、高膽固醇血症、白塞氏病、肥胖等。 2022 年，高血壓是最大的內皮功能障礙市場佔有率持有者。預計 2022 年至 2028 年，糖尿病領域的年複合成長率最高。

基於最終用戶的見解

根據最終用戶，內皮功能障礙市場分為醫院、診斷中心、診所等。醫院是 2022 年最大的市場佔有率持有者，預計 2022 年至 2028 年年複合成長率最高。

此外，全世界患有糖尿病的人數正在廣泛成長。根據國際糖尿病聯盟（IDF）的預測，到2045年，糖尿病患者人數將從2020年的4.25億增加到6億。因此，糖尿病患者數量的增加推動了糖尿病領域內皮功能障礙市場的成長。

市場促進因素
- 心血管疾病發病率增加
- 高膽固醇、糖尿病和肥胖症的發病率上升
市場限制
- 內皮功能障礙篩查技術的缺點
市場機會
- 新型生物標記和治療策略的使用不斷增加
未來的趨勢
- 使用無創方法評估內皮功能障礙
影響分析

第 6 章：內皮功能障礙市場 - 全球分析

全球內皮功能障礙市場收入預測與分析
全球內皮功能障礙市場（按地理位置）-預測與分析
關鍵參與者的市場定位

第 7 章：內皮功能障礙市場分析 - 按原因

概述
內皮功能障礙市場，按原因分類，2022 年和 2028 年 (%)
高血壓
糖尿病
高膽固醇血症
白塞病
肥胖
其他

第 8 章：內皮功能障礙市場分析 - 按測試類型

概述
內皮功能障礙市場，按測試類型，2022 年和 2028 年 (%)
侵入性測試
非侵入性測試

第 9 章：內皮功能障礙市場分析 - 按最終用戶

概述
內皮功能障礙市場，按最終用戶分類，2022 年和 2028 年 (%)
醫院
診斷中心
診所
其他

第 10 章：內皮功能障礙市場 - 2028 年收入和預測 - 地理分析

北美
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 亞太地區其他地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：COVID-19 大流行對內皮功能障礙市場的影響

北美
歐洲
亞太地區
南美洲和中美洲
中東和非洲

第 12 章：內皮功能障礙市場-行業格局

概述
內皮功能障礙市場的成長策略
無機成長策略
- 概述
有機成長策略
- 概述

第 13 章：公司簡介

ZOLL Medical Corp
Sphingo Tec GmbH
Lawrence Berkeley National Laboratory
The Polymath Co
Endothelix Inc
Perimed AB
SMART Medical Ltd
Everist Health Inc
Alam Medical SaRl
Medizinische Messtechnik GmbH

第 14 章：附錄

關於 Insight Partners
專業術語

簡介目錄圖表

Product Code: TIPRE00011290

The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach a value of US$ 2,584.84 million by 2028; the market is estimated to record a CAGR of 4.4% from 2022 to 2028. The market growth is attributed to increasing incidence of cardiovascular diseases and rising incidence of high cholesterol, diabetes, and obesity.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths. According to an article entitled "Young Indians Are at Higher Risk of Coronary Artery Disease," by Dr. O. Yadava, C.E.O. & Chief Cardiac Surgeon, National Heart Institute, New Delhi, current scientific evidence shows alarming results; CAD rates among Indians are staggering 50-400% higher than any other ethnic group. The prevalence of CAD in the West has fallen by half over the past three decades. However, the rates in India have doubled, and there is no sign of a decline.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. According to reports by the European Society of Cardiology, CVDs cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). In short, they account for 45% of all deaths in Europe. Over the past 25 years, the absolute number of CVD cases and new CVD cases have increased in Europe. There is a high prevalence of cardiovascular risk factors in Central and Western Europe owing to smoking habits and heavy drinking rates among men. More than 4 million Europeans die yearly from cardiovascular diseases mainly due to coronary artery disease (CHD) and stroke. As per the report "Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific," by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, which is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is more prone to develop this condition.

According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Further, CVD deaths have increased by 48% over the past 30 years, which accounted for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized CVD mortality rates in the Middle East & North Africa ranged from 134.2 to 600.2 per 100,000 people.

Therefore, the high prevalence of cardiovascular diseases is likely to drive the endothelial dysfunction market growth.

Product-Based Insights

The endothelial dysfunction market, based on cause, is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. The hypertension segment held the largest share of the market in 2022. However, diabetes segment is anticipated to register the highest CAGR of 4.6% in the market during 2022-2028. Cardiovascular complications are the results of chronic vascular complications caused by diabetes. Many research articles have shown links between insulin resistance and endothelial dysfunction. However, it is still not understood how diabetes affects endothelium. Diabetes is directly related to risks of microvascular pathologies, such as atherosclerotic diseases, retinopathy, nephropathy, and neuropathy. Thus, the risk of cardiovascular disease increases exponentially in patients suffering from diabetes. According to the research article 'Endothelial Dysfunction in Diabetes,' published in May 2020 by MDPI journals, patients with prediabetic conditions, such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also show accumulating evidence that implicates endothelial dysfunction as an event. Considering the above-listed factors, the demand for endothelial dysfunction treatment is estimated to increase exponentially.

Cause-Based Insights

Based on cause, the endothelial dysfunction market is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. Hypertension was the largest endothelial dysfunction market share holder in 2022. The diabetes segment is anticipated to register the highest CAGR from 2022 to 2028.

End User-Based Insights

Based on end user, the endothelial dysfunction market is categorized into hospitals, diagnostic centers, clinics, and others. Hospitals was the largest market share holder in 2022 and is anticipated to register the highest CAGR from 2022 to 2028.

Further, the number of people with diabetes is growing widely worldwide. According to the International Diabetes Federation (IDF), by 2045, the number of people with diabetes will rise to 600 million from 425 million in 2020. Thus, the growing number of diabetic people drives the endothelial dysfunction market growth for the diabetes segment.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the endothelial dysfunction market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Endothelial Dysfunction Market - by Cause
- 1.3.2 Global Endothelial Dysfunction Market - by Test Type
- 1.3.3 Global Endothelial Dysfunction Market - by End User
- 1.3.4 Global Endothelial Dysfunction Market - by Geography

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Endothelial Dysfunction Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Endothelial Dysfunction Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidences of Cardiovascular Diseases
- 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
- 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
- 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
- 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis

6. Endothelial Dysfunction Market - Global Analysis

6.1 Global Endothelial Dysfunction Market Revenue Forecast and Analysis
6.2 Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Endothelial Dysfunction Market Analysis - by Cause

7.1 Overview
7.2 Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
- 7.3.1 Overview
- 7.3.2 Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
- 7.5.1 Overview
- 7.5.2 Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
- 7.6.1 Overview
- 7.6.2 Behcet's Disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
- 7.7.1 Overview
- 7.7.2 Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Endothelial Dysfunction Market Analysis - by Test Type

8.1 Overview
8.2 Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
- 8.3.1 Overview
- 8.3.2 Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
- 8.4.1 Overview
- 8.4.2 Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Flow Mediated Dilatory
  - 8.4.3.1 Overview
  - 8.4.3.2 Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.4 Venous Occlusion Plethysmography
  - 8.4.4.1 Overview
  - 8.4.4.2 Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.5 Peripheral Arterial Tonometry (PAT)
  - 8.4.5.1 Overview
  - 8.4.5.2 Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Circulating Markers
  - 8.4.6.1 Overview
  - 8.4.6.2 Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.7 Others
  - 8.4.7.1 Overview
  - 8.4.7.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Endothelial Dysfunction Market Analysis - by End User

9.1 Overview
9.2 Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
- 9.4.1 Overview
- 9.4.2 Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
- 9.5.1 Overview
- 9.5.2 Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

10.1 North America: Endothelial Dysfunction Market
- 10.1.1 Overview
- 10.1.2 North America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.3 North America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.4 North America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.1.4.1 North America: Endothelial Dysfunction Market, by Non-Invasive Tests- 2020-2028 (US$ Million)
- 10.1.5 North America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.1.1 Overview
    - 10.1.5.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.2.1 Overview
    - 10.1.5.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.3.1 Overview
    - 10.1.5.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.2 Europe: Endothelial Dysfunction Market
- 10.2.1 Overview
- 10.2.2 Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.2.3 Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.2.4 Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.2.4.1 Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
- 10.2.5 Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.1.1 Overview
    - 10.2.5.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.2.1 Overview
    - 10.2.5.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.3.1 Overview
    - 10.2.5.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.4.1 Overview
    - 10.2.5.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.5.1 Overview
    - 10.2.5.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.6.1 Overview
    - 10.2.5.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.3 Asia Pacific: Endothelial Dysfunction Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.3 Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.3.4 Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
  - 10.3.4.1 Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.3.5 Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.1.1 Overview
    - 10.3.5.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.2.1 Overview
    - 10.3.5.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.3.1 Overview
    - 10.3.5.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.4.1 Overview
    - 10.3.5.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.5.1 Overview
    - 10.3.5.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.6.1 Overview
    - 10.3.5.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.4 Middle East & Africa: Endothelial Dysfunction Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4.3 Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.4.4 Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
  - 10.4.4.1 Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.4.5 Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.1 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.1.1 Overview
    - 10.4.5.1.2 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.2.1 Overview
    - 10.4.5.2.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.3 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.3.1 Overview
    - 10.4.5.3.2 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.4 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.4.1 Overview
    - 10.4.5.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.5 South & Central America: Endothelial Dysfunction Market
- 10.5.1 Overview
- 10.5.2 South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5.3 South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.5.4 South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.5.4.1 South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
- 10.5.5 South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.1 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.1.1 Overview
    - 10.5.5.1.2 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.1.3 Brazil: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.1.4 Brazil: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.1.4.1 Brazil: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.1.5 Brazil: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.2.1 Overview
    - 10.5.5.2.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.2.3 Argentina: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.2.4 Argentina: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.2.4.1 Argentina: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.2.5 Argentina: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.3 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.3.1 Overview
    - 10.5.5.3.2 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.3.3 Rest of South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.3.4 Rest of South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.3.4.1 Rest of South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.3.5 Rest of South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Endothelial Dysfunction Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Endothelial Dysfunction Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 ZOLL Medical Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sphingo Tec GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Lawrence Berkeley National Laboratory
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 The Polymath Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Endothelix Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Perimed AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 SMART Medical Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Everist Health Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Alam Medical SaRl
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Medizinische Messtechnik GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Techniques Used in to Assess Endothelial Function
Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
Table 3. North America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 28. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 32. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 34. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 38. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 42. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 50. Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 52. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 54. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 58. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 59. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 60. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 62. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 69. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 70. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 78. Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 83. UAE Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 84. UAE Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. UAE Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 89. South Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 90. South Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 93. Rest of Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 94. Rest of Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 95. South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 96. South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 97. South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 98. South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 101. Brazil Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 102. Brazil Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 105. Argentina Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 106. Argentina Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 109. Rest of South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 110. Rest of South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 111. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
Table 112. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
Table 113. Glossary of Terms, Endothelial dysfunction market

List Of Figures

Figure 1. Endothelial Dysfunction Market Segmentation
Figure 2. Endothelial Dysfunction Market by Region
Figure 3. Global Endothelial Dysfunction Market Overview
Figure 4. Hypertension Account for Largest Share of Cause Segment in Endothelial Dysfunction Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Endothelial Dysfunction Market, by Geography (US$ Million)
Figure 7. Global Endothelial Dysfunction Market - Leading Country Markets (US$ Million)
Figure 8. Global Endothelial Dysfunction Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
Figure 16. Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Endothelial Dysfunction Market
Figure 18. Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
Figure 19. Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Behcet's disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
Figure 26. Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
Figure 34. Hospitals and Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 41. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 45. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 47. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 54. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 56. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 63. Middle East & Africa Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 65. Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. South & Central America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 70. South & Central America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. South & Central America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 72. Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 75. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 76. Impact of COVID-19 Pandemic on European Countries Markets
Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 78. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 79. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 80. Growth Strategies in the Endothelial Dysfunction Market